CAS: 827318-97-8 - Danusertib
Formula:C26H30N6O3
InChI:InChI=1/C26H30N6O3/c1-30-12-14-31(15-13-30)20-10-8-19(9-11-20)25(33)27-24-21-16-32(17-22(21)28-29-24)26(34)23(35-2)18-6-4-3-5-7-18/h3-11,23H,12-17H2,1-2H3,(H2,27,28,29,33)/t23-/m1/s1
- Synonyms:
- N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
- N-{5-[(2R)-2-methoxy-2-phenylacetyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl}-4-(4-methylpiperazin-1-yl)benzamide
N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
CAS:827318-97-8
Formula:
C26H30N6O3
Purity:
%
Color and Shape:
Solid
Molecular weight:
474.5548
Ref: IN-DA003P8P
1mg | 91.00 € | ||
10mg | 199.00 € | ||
25mg | 239.00 € | ||
100mg | 247.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Danusertib
CAS:827318-97-8
Danusertib (PHA-739358) is a small-molecule 3-aminopyrazole derivative with potential antineoplastic activity.
Formula:
C26H30N6O3
Purity:
98% - 98.44%
Color and Shape:
White Powder
Molecular weight:
474.55
Ref: TM-T2094
1mg | 59.00 € | ||
2mg | 83.00 € | ||
5mg | 114.00 € | ||
10mg | 185.00 € | ||
25mg | 359.00 € | ||
50mg | 546.00 € | ||
100mg | 779.00 € | ||
500mg | 1,574.00 € | ||
1mL*10mM (DMSO) | 121.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Ref: 7W-GW8108
1mg | 276.00 € | ||
5mg | 430.00 € | ||
10mg | 729.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Danusertib
CAS:827318-97-8
Inhibitor of aurora kinases
Formula:
C26H30N6O3
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
474.57 g/mol
Ref: 3D-FD20793
10mg | 314.00 € | ||
50mg | 874.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
Danusertib
CAS:827318-97-8
Applications An Aurora kinase inhibitor, used to treat patients with chromic myeloid leukemia. It is …
Formula:
C26H30N6O3
Color and Shape:
Neat
Molecular weight:
474.55
Ref: TR-D185070
5mg | 259.00 € | ||
50mg | 1,514.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025